online ISSN 2415-3176
print ISSN 1609-6371
logoExperimental and Clinical Physiology and Biochemistry
J. 2023, 97(3): 42–51
https://doi.org/10.25040/ecpb2023.03.042

Clinical medicine


Systemic osteoporosis and osteopenia in men with hyperuricemia

H. S. DUBETSKA, E. Y. SKLYROV
Abstract

Abstract. The article presents the results of own research on the study of the incidence of osteoporosis and osteopenia in men with different levels of uric acid and the influence of hyperuricemia on the mineral density of bone tissue. The aim of the study was to examine the structural and functional state of bone tissue (indicators of mineral density) in men with different levels of uric acid and to establish the incidence of osteoporosis and osteopenia in patients with hyperuricemia.

Materials and methods of research. 140 men aged 50–80 years were examined. Determination of the level of uric acid in the serum was performed using the uricase-peroxidase method. Determination of bone mineral density was performed by DXA on the device «Prodigy».

Results. It has been established that the incidence of osteoporosis and osteopenia in men with hyperuricemia is lower compared to men with normouricemia. When dividing by age groups 50–59 years, 60–69 years, 70–79 years in men with hyperuricemia, osteoporosis was detected only in the age group 70–79 years and its incidence was 14% at the level of the lumbar spine (L1–L4) and 14% at the level of the femoral neck (Neack Mean). According to the quarterly distribution according to the level of uric acid, men with the highest level of uric acid had the highest indicators of bone mineral density.

Conclusions. Patients with a high level of uric acid have high levels of bone mineral density, so they are less likely to develop diseases such as osteoporosis and osteopenia, which indicates the protective role of uric acid for bone tissue and may be of practical importance when deciding on the issue of drug correction of hyperuricemia.

Article recieved: 28.08.2023

Keywords: osteoporosis, osteopenia, hyperuricemia, uric acid, bone mineral density

Full text: PDF (Ukr)

References
  1. Поворознюк В. В, Григор'єва Н. В, Дєдух Н. В. Вторинний остеопороз . Кропивницький: Поліум; 2021. 528 с.
  2. Джус М. Б. Глюкокортикоїдний остеопороз: проблема профілактики і лікування в ревматологічній практиці. Медицина залізничного транспорту України. 2004;3:73-83.
  3. Поворознюк В. В. Захворювання кістково-м'язової системи в людей різного віку (вибрані лекції, огляди, статті). У 3-х томах. Том 1. Київ; 2004. 480 с.
  4. Cauley JA. Osteoporosis: fracture epidemiology update 2016. Curr Opin Rheumatol. 2017;29(2):150-156.doi.org/10.1097/BOR.0000000000000365
  5. Yang T, Chu CH, Bai CH et al. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis. 2012;220(2):525-531.doi.org/10.1016/j.atherosclerosis.2011.11.014
  6. Chiou W, Wang M, Huang D, et al. The Relationship between Serum Uric Acid Level and Metabolic Syndrome: Differences by Sex and Age in Taiwanese. J Epidemiol. 2010;20(3):219-224.doi.org/10.2188/jea.JE20090078
  7. Zoccali C, Mallamaci F. Uric acid, hypertension, and cardiovascular and renal complications. Curr Hypertens Rep. 2013;15(6):531-537.doi.org/10.1007/s11906-013-0391-y
  8. Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. Int J Mol Sci. 2021; 22(17): 9221.doi.org/10.3390/ijms22179221
  9. Li CH, Lee CL, Hsieh YC, et al. Hyperuricemia and diabetes mellitus when occurred together have higher risks than alone on all-cause mortality and end-stage renal disease in patients with chronic kidney disease. BMC Nephrol. 2022;23:157.doi.org/10.1186/s12882-022-02755-1
  10. Burnier M. Gout and hyperuricaemia: modifiable cardiovascular risk factors? Front Cardiovasc Med. 2023;10:1190069.doi.org/10.3389/fcvm.2023.1190069
  11. Barman Z, Hasan M, Miah R, et al. Association between hyperuricemia and chronic kidney disease: a cross-sectional study in Bangladeshi adults. BMC Endocr Disord. 2023;23:45.doi.org/10.1186/s12902-023-01304-7
  12. Wang C, Qin P, Liu Y, et al. Association between hyperuricemia and hypertension and the mediatory role of obesity: a large cohort study in China. Rev Assoc Med Bras.2023;69(8):e20220241.doi.org/10.1590/1806-9282.20220241
  13. Zhou Y, Li J, Ma Y. Elevated serum uric acid is associated with the risk of advanced staging and vascular involvement in patients with hepatoblastoma: a 14-year retrospective study. Front Oncol. 2023; 13: 1144349.doi.org/10.3389/fonc.2023.1144349
  14. Дзяк Г. В, Хомазюк Т. А. Подагра: «Капкан» метаболічних проблем: Наукове видання. 2010:112.
  15. Шуба Н. М. Гіперурикемія - мультиморбідна патологія в ревматології. Український ревматологічний журнал. 2013;2(52):14-22.
  16. Terkeltaub R. Gout and other crystal arthropathies. 2012:357.
  17. Ahn SH, Lee SH, Kim BJ, et al. Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women. Osteoporos Int. 2013;24(12):2961-2970.doi.org/10.1007/s00198-013-2377-7
  18. Makovey J, Macara M, Chen JS, et al. Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: a longitudinal study. Bone. 2013;52(1):400-406.doi.org/10.1016/j.bone.2012.10.025
  19. Nabipour I, Sambrook PN, Blyth FM, et al. Serum uric acid is associated with bone health in older men: a cross-sectional population-based study. J Bone Miner Res. 2011;26(5):955-964.doi.org/10.1002/jbmr.286
  20. Li JY, Lee JI, Cheng-Chang Lu CC, et al. Hyperuricemia and Its Association with Osteoporosis in a Large Asian Cohort. Nutrients. 2022;14(11):2206.doi.org/10.3390/nu14112206
  21. Lee JW, Kwon BC, Choi HG. Analyses of the relationship between hyperuricemia and osteoporosis. Sci Rep. 2021;11:12080.doi.org/10.1038/s41598-021-91570-z
  22. Ibrahim WN, Younes N, Shi Z, Abu-Madi MA. Serum Uric Acid Level Is Positively Associated With Higher Bone Mineral Density at Multiple Skeletal Sites Among Healthy Qataris. Front Endocrinol (Lausanne). 2021;12:653685.doi.org/10.3389/fendo.2021.653685
  23. Yan D, Jie Wang J, Hou X. Association of serum uric acid levels with osteoporosis and bone turnover markers in a Chinese population. Acta Pharmacol Sin. 2018;39(4):626-632.doi.org/10.1038/aps.2017.165
  24. Xu M, Lu K, Yang X. Association between serum uric acid levels and bone mineral density in patients with osteoporosis: a cross-sectional study. BMC Musculoskelet Disord. 2023;24:306.doi.org/10.1186/s12891-023-06414-w


Програмування - Roman.im | QR-Code Generator